Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes R Saad, MR Rizkallah, RK Aziz Gut pathogens 4 (1), 16, 2012 | 168 | 2012 |
Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics M ElRakaiby, BE Dutilh, MR Rizkallah, A Boleij, JN Cole, RK Aziz Omics: a journal of integrative biology 18 (7), 402-414, 2014 | 164 | 2014 |
The Human Microbiome Project, personalized medicine and the birth of pharmacomicrobiomics MR Rizkallah, R Saad, RK Aziz Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2010 | 109 | 2010 |
Drug pharmacomicrobiomics and toxicomicrobiomics: From scattered reports to systematic studies of drug–microbiome interactions RK Aziz, SM Hegazy, R Yasser, MR Rizkallah, MT ElRakaiby Expert Opinion on Drug Metabolism & Toxicology 14 (10), 1043-1055, 2018 | 41 | 2018 |
The biogeographic differentiation of algal microbiomes in the upper ocean from pole to pole K Martin, K Schmidt, A Toseland, CA Boulton, K Barry, B Beszteri, ... Nature Communications 12 (1), 5483, 2021 | 34 | 2021 |
The PharmacoMicrobiomics Portal: A Database for Drug-Microbiome Interactions M R Rizkallah, S Gamal-Eldin, R Saad, R K Aziz Current Pharmacogenomics and Personalized Medicine 10 (3), 195-203, 2012 | 28 | 2012 |
PharmacoMicrobiomics or how bugs modulate drugs: an educational initiative to explore the effects of human microbiome on drugs RK Aziz, R Saad, MR Rizkallah BMC Bioinformatics 12 (Suppl 7), A10, 2011 | 26 | 2011 |
Deciphering Patterns of Adaptation and Acclimation in the Transcriptome of Phaeocystis antarctica to Changing Iron Conditions1 MR Rizkallah, S Frickenhaus, S Trimborn, L Harms, A Moustafa, V Benes, ... Journal of phycology 56 (3), 747-760, 2020 | 12 | 2020 |
Translating pharmacomicrobiomics: three actionable challenges/prospects in 2020 RK Aziz, MR Rizkallah, R Saad, MT ElRakaiby Omics: a journal of integrative biology 24 (2), 60-61, 2020 | 7 | 2020 |
Aufdeckung von Arzneimittelrisiken nach der Zulassung: Methodenentwicklung zur Nutzung von Routinedaten der gesetzlichen Krankenversicherungen R Foraita, L Dijkstra, F Falkenberg, M Garling, R Linder, R Pflock, ... Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 61 (9), 1075-1081, 2018 | 2 | 2018 |
Detection of drug risks after approval: Methods development for the use of routine statutory health insurance data R Foraita, L Dijkstra, F Falkenberg, M Garling, R Linder, R Pflock, ... Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 61, 1075-1081, 2018 | 1 | 2018 |
Transcriptomics of iron limitation in Phaeocystis antarctica MRR Issak The American University in Cairo, 2014 | 1 | 2014 |
Challenges in Integration and Analysis of High-Dimensional Biological Data: Cases from Environmental and Health Research MR Rizkallah Jacobs University Bremen, 2022 | | 2022 |
Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs R Saad, MR Rizkallah, RK Aziz Gut, 2012 | | 2012 |